SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Google picks Biogen Idec MS project for research partnership

Google and Biogen Idec are teaming up to crack multiple sclerosis, the latest crossover between pharma and the wearables world.

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move that puts it on a collision course with French Biotech, Cellectis.

HCV drugs Sovaldi and Elysio boost Q1 sales for AmeriSourceBergen

New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in revenue for AmeriSourceBergen’s Pharmaceutical Distribution business.

people on the move

Who's making strides?

The World Health Organisation's regional director for Africa makes plans to tackle Ebola, plus more from AstraZeneca, TransCelerate, AmerisourceBergen, and more.

Industry welcomes Energy and Commerce paper to help expedite clinical trials

Guidance to remove red tape in the clinical trial process has been commended by the industry body ACRO.

Supply chain delays expected as Juno hits Northeast US

US Pharma firms are prepared for delays in the supply chain caused by Winter Storm Juno thanks to advanced planning and backup generators, says a logistics expert.

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Charles River considers re-opening preclinical site in Mass.

Charles River considers re-opening preclinical site in Massachusetts

CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the...

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel’s improved book-to-bill ratio is a reassuring sign for the company and the CRO industry as a whole,...

Crown expands Precos site to build caucasian cancer expertise

Crown expands Precos site to build caucasian cancer expertise

Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical...

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...